These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33563177)

  • 1. Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells.
    Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
    Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
    Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
    Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
    El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary gland stem cells and their application in breast cancer.
    Yang X; Wang H; Jiao B
    Oncotarget; 2017 Feb; 8(6):10675-10691. PubMed ID: 27793013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
    Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways governing breast cancer stem cells behavior.
    Song K; Farzaneh M
    Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin remodeling in mammary gland differentiation and breast tumorigenesis.
    Huang TH; Esteller M
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004515. PubMed ID: 20610549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.
    Wen S; Qin Y; Wang R; Yang L; Zeng H; Zhu P; Li Q; Qiu Y; Chen S; Liu Y; Hou Y; Tang X; Liu M; Tu G
    Cell Death Dis; 2021 May; 12(5):437. PubMed ID: 33934099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and metabolic regulation of breast cancer stem cells.
    Liu HX; Li XL; Dong CF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells.
    Flores-Huerta N; Silva-Cázares MB; Arriaga-Pizano LA; Prieto-Chávez JL; López-Camarillo C
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epigenetic modulation in cancer stem cell fate.
    Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
    Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1.
    Zhang T; Zhang W; Hao M
    Oncol Rep; 2021 Jan; 45(1):337-348. PubMed ID: 33416137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells.
    Samadani AA; Norollahi SE; Rashidy-Pour A; Mansour-Ghanaei F; Nemati S; Joukar F; Afshar AM; Ghazanfari S; Safizadeh M; Rostami P; Gatei M
    Biomed Pharmacother; 2018 Dec; 108():590-599. PubMed ID: 30243093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.